Community/Retail

New research results show that over the next decade COVID-19 may be more like the common cold.

David Silverstein, JD, MS, a partner in Axinn’s Intellectual Property Practice Group and FDA practice groups, discusses the implications of the White House support for the proposal presented to the WTO to waive IP protections for COVID-19 vaccines.

No cases of COVID-19 were observed in the vaccine group using the case definition from the adult phase 3 COVE study, compared to 4 cases in the placebo group.

Pharmacy team members can provide educational resources, strategies to kids to promote safety.

A study published in Nature may document a previously unknown interaction between gut microbes and the thymus, an immune system organ.

High antibody levels were also generated in participants with evidence of a prior SARS-CoV-2 infection, suggesting that this could be developed as a booster.

The combination of stress at work and at home has impacted the mental health of many women pharmacists during the COVID-19 pandemic.

Addressing the underlying causes of pharmacist burnout is essential, according to Melissa Santibañez, PharmD, BCCCP, a critical care clinical pharmacist at Memorial Regional Hospital.

Occupational exposure to certain medications and long hours standing may increase risk.

According to the study authors, this model provides insights into the multiscale biological alterations in the elderly and neurodegenerative brain, which have important implications for identifying treatment targets for Alzheimer disease.

Researchers found no evidence of abnormal blood flow between the mother and fetus or problems with fetal blood flow following COVID-19 vaccination.

Guillermo Rodriguez Navarrete, the founder and CEO of Nutrillermo, and Elaine Ladd, the chief pharmacy officer of Pharmacy Development Services (PDS), discuss the value of the pharmacist in the health and wellness space for patients.

Pharmacy Times spoke with Lauren Simko, managing performance specialist at Pharmacy Development Services, about the future of lengthening the patient lifecycle and further developing pharmacy services.

Pharmacy Times spoke with Lauren Simko, managing performance specialist at Pharmacy Development Services, about how elevating the patient experience can increase revenue for pharmacists in the healthcare space.

Guillermo Rodriguez Navarrete, the founder and CEO of Nutrillermo, and Elaine Ladd, the chief pharmacy officer of Pharmacy Development Services (PDS), discuss the role of social media in the health and wellness space.

The FDA has approved Verquvo (vericiguat; Merck) tablets for adults with chronic heart failure.

Final data from a phase 3 trial assessing evolocumab in patients with HIV who have high cholesterol confirmed the safety and efficacy of the drug as a treatment.

Guillermo Rodriguez Navarrete, the founder and CEO of Nutrillermo, and Elaine Ladd, the chief pharmacy officer of Pharmacy Development Services (PDS), discuss whether the shift in the public's awareness of the critical role of the pharmacist during the pandemic could support pharmacists’ move to a more significant role in the health and wellness space.

Individuals who took probiotics during the 6-month-long study had a 27% lower overall incidence of upper respiratory tract symptoms compared to the placebo group.

The study authors said that treating the condition has been difficult until now due to a lack of FDA-approved therapies.

Treatment options include medications and recommendations to improve hygiene.

Guillermo Rodriguez Navarrete, the founder and CEO of Nutrillermo, and Elaine Ladd, the chief pharmacy officer of Pharmacy Development Services (PDS), discuss challenges pharmacists may face while expanding into the health and wellness space.

Guillermo Rodriguez Navarrete, the founder and CEO of Nutrillermo, and Elaine Ladd, the chief pharmacy officer of Pharmacy Development Services (PDS), discuss the 2021 Virtual PDS Conference session on growth opportunities in the health and wellness space for pharmacy.

Hannah Fish, PharmD, associate director of strategic initiatives at NCPA, discusses the role of the pharmacist in vaccinating children ages 12 and older against COVID-19 following the FDA updating the Pfizer COVID-19 vaccine EUA.

In addition to improving health care access for patients, point-of-care testing in pharmacies can drive customer demand and satisfaction.

Vaccines that specifically target the receptor-binding domain of SARS-CoV-2 could be effective, as well as easy to manufacture and scale up.

Despite the stressors of the past year, students said the health care crisis has only reinforced the value of the pharmacist and their desire to enter the field.

Pharmacists can play a vital role in testing to improve medication outcomes in different practice settings.

It is important for pharmacists to understand the relationship between medication adherence and patient outcomes.